Clinical Trials | January 01, 2026
SOFIE Biosciences doses first patient in Phase 3 trial of novel cancer imaging agent
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
Clinical trial enrollment has long been a bottleneck in drug development
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
HYMPAVZI’s safety profile was generally favorable
Subscribe To Our Newsletter & Stay Updated
